Summary by Futu AI
Adam Lenkowsky, EVP and Chief Commercial Officer of Bristol-Myers Squibb (BMY), reported a transaction on May 1, 2024, involving the company's common stock. Following the transaction, Lenkowsky holds a total of 6,650 shares directly and 9,651.639 shares indirectly. The indirect holdings include 4,364.699 shares through the BMS Savings and Investment Program and 5,286.94 shares held by his spouse. The common stock is listed with a par value of $0.10.